Blue Bell Private Wealth Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Blue Bell Private Wealth Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20	Closed	–	–	883
2022 Q2	$0	Hold	20	–	–	﹤0.01%	934
2022 Q1	$0	Buy	+20	New	+$82	﹤0.01%	973

Other funds holding AVEO

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Blue Bell Private Wealth Management's AVEO Position: Q3 2022 in Review

Blue Bell Private Wealth Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2022, closing a stake of 20 shares.

Blue Bell Private Wealth Management first reported a position in AVEO in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 77 funds tracked by Wall St. Rank hold AVEO as of Q3 2022.

Blue Bell Private Wealth Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
Blue Bell Private Wealth Management sold 20 AVEO Pharmaceuticals, Inc. shares in Q3 2022.
Blue Bell Private Wealth Management first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2022 and held it in 2 quarters.
Blue Bell Private Wealth Management's AVEO Pharmaceuticals, Inc. position peaked at $0 in Q2 2022.
77 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2022.

Based on Blue Bell Private Wealth Management's 13F filing for Q3 2022, filed 9 Nov 2022.